Found: 193
Select item for more details and to access through your institution.
Back to basics, part 3: How to diagnose dry eye disease in only 5 minutes.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 20, p. 19
- By:
- Publication type:
- Article
Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 2, p. 619, doi. 10.1007/s00432-020-03365-w
- By:
- Publication type:
- Article
Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01135-2
- By:
- Publication type:
- Article
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00905-8
- By:
- Publication type:
- Article
Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00888-6
- By:
- Publication type:
- Article
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00883-x
- By:
- Publication type:
- Article
Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1352281
- By:
- Publication type:
- Article
Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database.
- Published in:
- Current Oncology, 2022, v. 29, n. 3, p. 1575, doi. 10.3390/curroncol29030132
- By:
- Publication type:
- Article
Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 1, p. 93, doi. 10.1111/bjh.18172
- By:
- Publication type:
- Article
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 6, p. 896, doi. 10.1111/bjh.14787
- By:
- Publication type:
- Article
Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1172, doi. 10.1177/10781552221103551
- By:
- Publication type:
- Article
Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN‐003/MYX.1 single arm phase II trial.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. 552, doi. 10.1002/ajh.26147
- By:
- Publication type:
- Article
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 5, p. 815, doi. 10.1111/ejh.14082
- By:
- Publication type:
- Article
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 1, p. 73, doi. 10.1111/ejh.13706
- By:
- Publication type:
- Article
Retrospective study of treatment patterns and outcomes post‐lenalidomide for multiple myeloma in Canada.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 4, p. 416, doi. 10.1111/ejh.13678
- By:
- Publication type:
- Article
The impact of lenalidomide maintenance on second‐line chemotherapy in transplant eligible patients with multiple myeloma.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 5, p. 673, doi. 10.1111/ejh.13596
- By:
- Publication type:
- Article
Bortezomib in Relapsed or Refractory Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 74
- By:
- Publication type:
- Article
Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 4, p. 4357, doi. 10.1002/cam4.5245
- By:
- Publication type:
- Article
Continuous lenalidomide and low‐dose dexamethasone in patients with transplant‐ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 23, p. 8923, doi. 10.1002/cam4.3511
- By:
- Publication type:
- Article
Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.826342
- By:
- Publication type:
- Article
Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 19, doi. 10.1016/j.clml.2012.08.009
- By:
- Publication type:
- Article
Dry eye in the US: Some new demographic data.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 19, p. 19
- By:
- Publication type:
- Article
Annual anti-inflammatory review.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 18, p. 24
- By:
- Publication type:
- Article
Summer breezes: Thoughts while I sits and thinks.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 16, p. 20
- By:
- Publication type:
- Article
Dry eye back to basics, part 1: It all starts with tears.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 14, p. 19
- By:
- Publication type:
- Article
Who should take care of dry eye?
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 12, p. 20
- By:
- Publication type:
- Article
An update on the dry eye doc with dry eye.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 4, p. 8
- By:
- Publication type:
- Article
Dry eye and the surgical patient: This is still a thing.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 16
- By:
- Publication type:
- Article
The Era of 'And': Combination therapy arrives.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 8, p. 19
- By:
- Publication type:
- Article
Compounded drugs an option for severe dry eye.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 6, p. 28
- By:
- Publication type:
- Article
Welcome 2024: New Year's review and resolutions.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 2, p. 34
- By:
- Publication type:
- Article
Dry eye diagnostics: A simple approach and shopping list.
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 24, p. 20
- By:
- Publication type:
- Article
Skin oil is bad for your eyes: A new theory to explain eva porative DED.
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 23, p. 20
- By:
- Publication type:
- Article
The magic of Miebo: Bausch + Lomb pulls a winner out of its hat.
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 22, p. 24
- By:
- Publication type:
- Article
Access is the issue: Out-of-pocket costs are all that matter when it comes to dry eye disease drugs.
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 20, p. 66
- By:
- Publication type:
- Article
Annual anti-inflammatory review: The most interesting market segment in eye care.
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 18, p. 14
- By:
- Publication type:
- Article
Sometimes I sits and thinks: Tiny thoughts on dry eye, reading and writing while sitting in the sun.
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 16, p. 8
- By:
- Publication type:
- Article
Time to talk about eva porative dry eye disease.
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 14, p. 24
- By:
- Publication type:
- Article
Brent Saunders is back! B+L acquires Xiidra.
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 14, p. 21
- By:
- Publication type:
- Article
Decision fatigue: A subtle sign may indicate burnout.
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 12, p. 28
- By:
- Publication type:
- Article
A (sadly) unavoidable review of OTC eye drops: If your patients insist on using over-the-counter artificial tears, make sure they do not contain preservatives.
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 10, p. 18
- By:
- Publication type:
- Article
Definitions and terms in dry eye: Do the words matter?
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 8, p. 8
- By:
- Publication type:
- Article
Again, to the surface.
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 6, p. 6
- By:
- Publication type:
- Article
Cultivate, curate culture of compassion in your practice.
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 4, p. 6
- By:
- Publication type:
- Article
New Year's dry eye resolutions.
- Published in:
- Ocular Surgery News, 2023, v. 41, n. 2, p. 22
- By:
- Publication type:
- Article
Cold weather, hot takes: Industry on the move.
- Published in:
- Ocular Surgery News, 2022, v. 40, n. 24, p. 24
- By:
- Publication type:
- Article
Do we really need another cyclosporine drop?
- Published in:
- Ocular Surgery News, 2022, v. 40, n. 21, p. 38
- By:
- Publication type:
- Article
When beauty is the beast, part 2.
- Published in:
- Ocular Surgery News, 2022, v. 40, n. 22, p. 20
- By:
- Publication type:
- Article
When beauty is the beast, part 1.
- Published in:
- Ocular Surgery News, 2022, v. 40, n. 20, p. 32
- By:
- Publication type:
- Article
When the going gets weird.
- Published in:
- Ocular Surgery News, 2022, v. 40, n. 18, p. 28
- By:
- Publication type:
- Article